Bliss GVS Pharma Ltd.

₹267.35

-1.9 (-0.7%)

BLISSGVS Share Price

Pharmaceuticals & Biotechnology

As on April 29, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 2,848 Cr

P/E Ratio33.42

Dividend Yield0.19 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	268.36	Bearish
10-DMA	264.5	Bullish
20-DMA	254.12	Bullish
50-DMA	230.81	Bullish
100-DMA	199.75	Bullish
200-DMA	179.22	Bullish

Historical Performance

1 Year

117.2%

3 Years

249.2%

5 Years

163.7%

10 Years

122.4%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	8,097	7,702	7,516	7,475	5,772
Total Expenditure	6,830	6,196	6,343	6,291	4,706
Other Income	365	287	178	315	220
Operating Profit	1,632	1,794	1,351	1,498	1,286
Interest	81	69	104	47	72
Depreciation	294	264	187	173	172
Profit Before Tax	1,256	1,169	1,061	542	1,041
Consolidated Net Profit	843	755	709	150	685
Adjusted EPS	8	7	7	1	7

Compounded Sales Growth

10 Years:8.2

5 Years:3.3

3 Years:1.6

TTM:1

Compounded Profit Growth

10 Years:0.4

5 Years:-2.8

3 Years:41.2

TTM:2.2

Stock Price CAGR

10 Years:8.3

5 Years:21.4

3 Years:51.7

TTM:125.1

Return on Equity

10 Years:8

5 Years:6.6

3 Years:6.8

last year:8

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	105	105	104	104	103
Total Reserves	10,335	9,490	8,646	7,984	7,881
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	373	512	428	292	452
Other Current Liabilities	730	625	582	678	537
Short Term Borrowings	229	321	460	607	650
Total Liabilities	13,008	12,116	11,535	11,088	10,768
Capital Work in Progress	207	78	28	222	24
Long Term Loans & Advances	166	147	176	244	126
Currents Investments	---	6	50	---	---
Short Term Loans and Advances	273	549	946	685	403
Total Current Assets	8,193	8,109	6,974	7,769	7,652
Total Assets	13,008	12,116	11,535	11,088	10,768
Adjusted Book Value	99	92	84	78	77

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 33.42, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 51.5%, indicating sustained price appreciation.
The stock carries a high beta of 1.5, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹1632 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹8097 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 2250231.5

No. of Shares: 8417 (Approx)

Performance:125%

P/L: ₹1250231.5

NIFTY Performance: -0.6%

1 day Top Gainers